Edap Tms (NASDAQ:EDAP) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell?

Edap Tms S.A. (NASDAQ:EDAP)’s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.30 and traded as high as $3.93. Edap Tms shares last traded at $3.69, with a volume of 182,371 shares trading hands.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Edap Tms in a research report on Monday, December 29th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $2.00 price target on shares of Edap Tms in a report on Thursday, November 6th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Edap Tms currently has a consensus rating of “Hold” and an average target price of $8.50.

Edap Tms Trading Down 9.1%

The stock has a market capitalization of $137.97 million, a price-to-earnings ratio of -6.47 and a beta of -0.26. The company has a debt-to-equity ratio of 0.04, a quick ratio of 0.97 and a current ratio of 1.41. The business has a 50-day moving average of $2.93 and a 200-day moving average of $2.30.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings results on Thursday, November 6th. The medical equipment provider reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.26) by $0.11. The company had revenue of $16.29 million for the quarter, compared to analyst estimates of $15.05 million. Edap Tms had a negative return on equity of 61.60% and a negative net margin of 30.95%. As a group, research analysts forecast that Edap Tms S.A. will post -0.6 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Financial Planning Navigators CORP acquired a new position in Edap Tms in the fourth quarter valued at $33,000. Simplicity Wealth LLC acquired a new position in Edap Tms in the 2nd quarter valued at about $54,000. Finally, Sage Mountain Advisors LLC purchased a new stake in Edap Tms during the 2nd quarter valued at approximately $165,000. 62.74% of the stock is owned by hedge funds and other institutional investors.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.